 Most PCI patients are at very high CV risk, and as such here is an increased need for intensive lipid management in PCI patients and the population is well suited to demonstrating rosuvastatins LDL-C lowering efficacy.Most PCI patients are at very high CV risk, and as such here is an increased need for intensive lipid management in PCI patients and the population is well suited to demonstrating rosuvastatins LDL-C lowering efficacy.The purpose of this study is to observe the effectiveness of statins on lipid level reduction LDL-C, HDL-C, TG, and non-HDL-C and lipid goal attainment according to recent guidelines. 